期刊文献+

米非司酮联合甲睾酮治疗围绝经期妇女子宫肌瘤的临床疗效观察 被引量:2

Clinical Observation of Mifepristone Combined with Methyltestosterone in the Treatment of Uterine Fibroids in Perimenopausal Women
下载PDF
导出
摘要 目的观察米非司酮联合甲睾酮治疗围绝经期妇女子宫肌瘤的临床效果。方法选择2014年6月至2016年6月收治的80例围绝经期子宫肌瘤妇女,按照随机数字表法分为两组,每组40例。对照组给予米非司酮治疗,观察组采用米非司酮联合甲睾酮方法治疗。治疗24周后,观察治疗前后两组患者的孕酮(P)、促卵泡激素(FSH)、黄体生成素(LH)、雌二醇(E2)等激素水平,观察子宫体积、肌瘤体积和血红蛋白水平的变化,比较两组患者的临床疗效及不良反应发生情况。结果治疗前,两组患者各激素水平、子宫体积、肌瘤体积和血红蛋白水平比较差异均无统计学意义(P>0.05);治疗后,观察组患者各激素水平、子宫体积、肌瘤体积和血红蛋白水平改善情况明显优于对照组(P<0.05);观察组患者治疗总有效率为95.00%,优于对照组为82.50%(P<0.05),两组不良反应比较差异无统计学意义(P>0.05)。结论米非司酮联合甲睾酮治疗围绝经期子宫肌瘤的临床效果确切,可有效改善患者机体微循环及性激素水平,促使肌瘤缩小,改善贫血,缓解临床症状。 Objective To observe the clinical effect of mifepristone combined with methyltestosterone in the treatment of uterine fibroids in perimenopausal women. Methods Forty-eight women with perimenopausal uterine fibroids who were treated in June 2014 and June 2016 were divided into two groups according to the random number table method. The control group was treated with mifepristone,and the observation group was treated with mifepristone combined with methyltestosterone. After 24 weeks of treatment,the levels of progesterone( P),follicle stimulating hormone( FSH),luteinizing hormone( LH) and estradiol( E2) were observed before and after treatment.The uterine volume,fibroid volume and Hemoglobin levels were compared,compared between the two groups of patients with clinical efficacy and adverse reactions occurred. Results There were no significant differences in hormone levels,uterine volume,fibroid volume and hemoglobin level between the two groups before treatment( P 〉 0.05). After treatment,the levels of hormone,uterine volume,fibroid volume and( P 〈 0. 05). The total effective rate was 95. 00% in the observation group and 82. 50%( P 〈 0. 05). There was no significant difference between the two groups( P 〉 0. 05). Conclusion The hemoglobin level of the two groups was significantly higher than that of the control group( P 〈 0. 05). Conclusion Mifepristone combined with methyltestosterone in the treatment of perimenopausal uterine fibroids is effective and can improve the microcirculation and sex hormone levels of the patients,promote fibroids to reduce the anemia and alleviate the clinical symptoms.
作者 刘纯 LIU Chun(Zhumadian Chinese medicine hospital, Zhumadian 463000 Chin)
出处 《内蒙古医学杂志》 2017年第4期398-400,共3页 Inner Mongolia Medical Journal
关键词 米非司酮 甲睾酮 围绝经期 子宫肌瘤 mifepristone methyltestosterone perimenopausal uterine fibroids
  • 相关文献

参考文献9

二级参考文献96

  • 1梁义娟,刘众毅,刘素敏.子宫肌瘤的药物治疗[J].河北职工医学院学报,2002,19(1):54-55. 被引量:12
  • 2廖爱华.米非司酮的作用机理及临床应用[J].实用妇产科杂志,1994,10(1):15-16. 被引量:532
  • 3乐杰.妇产科[M].北京:人民卫生出版社,2004.354.
  • 4Parazzini F,Chiaffarino F,Polverion G,et a1.Uterine fibroids risk and history of selected medical conditions linked with femal hormones[J].Eur J Epidcmiol,2004,19(3):249.
  • 5Koshiyama M,Morita Y,Fujii H,et al.Gynecologic malignancies accompanied by hormone-dependent disease[J].Menopause,2001,8(2):149.
  • 6乐杰.妇产科学[M].北京:人民卫生出版社,2003.360.
  • 7乐杰.妇产科学[M].6版.北京:人民卫生出版社,2005:145.
  • 8Strissel P L, Swiatek J, Oppelt P, et al. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients[ J]. J Steroid Biochem Mol Biol, 2007,107(1-2) :42-47.
  • 9Islam MS, Protic O, Giannubilo SR, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options [ J]. J Clin Endocrinol Metab,2013,98 (3) :921-934.
  • 10Lewicka A, Osuch B, Cendrowski K, et al. Expression of vascular endothelial growth factor mRNA in human leiomyomas[ J ]. Gynecol Endocrino1,2010,26 (6) :451-455.

共引文献159

同被引文献20

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部